相关实验视频
Updated: May 30, 2025

08:36
Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
Published on: April 7, 2023
987
氨酸功能化托法西提尼布装载的转基因组用于针对性药物输送在类风湿性关节炎
Pavani Chowdary1,2, Eswara Rao Puppala3, Chandra Lekha Putta1
1Department of Biomedical Engineering, Indian Institute of Technology Hyderabad, Kandi 502284, Telangana, India.
ACS applied bio materials
|January 29, 2025
概括
覆盖着 hialuronic 酸的 transethosomes 提供针对性局部传递托法西提尼布的类风湿性关节炎,减少全身副作用. 与传统治疗相比,这种新的HA-TOF-TE系统显示出显著的抗炎作用和更好的疗效.
科学领域:
- 纳米技术纳米技术
- 药理学 药理学是指药理学的学科.
- 类风湿病学 类风湿病学
背景情况:
- 口服托法西替尼 (TOF) 对类风湿性关节炎 (RA) 有效,但会引起全身副作用.
- 需要有针对性的局部输送系统来提高RA治疗的疗效和降低毒性.
研究的目的:
- 开发和评估氨酸涂层的转基因组 (HA-TOF-TE) 用于针对性地局部输送托法西提尼布 (TOF).
- 评估HA-TOF-TE降低系统毒性和提高类风湿性关节炎治疗疗效的潜力.
主要方法:
- 转基因组 (TE) 通过冷声波合成,并用氨酸 (HA) 功能化.
- 配方的特点是粒子大小,泽塔潜力和捕获效率.
- 在小鼠模型中评估了体外药物释放,体外皮肤透性和体内抗炎疗效.
主要成果:
- 优化HA-TOF-TE的颗粒大小为151.5nm,并且具有很高的捕获效率.
- 活体研究表明,HA-TOF-TE的皮肤保留和药物流量增加.
- 在体内研究表明,HA-TOF-TE在关节炎大鼠中具有显著的抗炎作用,具有减少的促炎细胞因子 (IL-1,IL-6,PGE-2) 和基因表达 (IL-6,CD44,原II).
结论:
- 覆盖着 hialuronic 酸的 transethosomes 提供了一个有效的针对性输送系统为托法西提尼布在类风湿性关节炎.
- HA-TOF-TE显著减少炎症和全身副作用,为传统的口服托法西提尼布治疗提供了一个有前途的替代方案.
关键词:
氨酸是什么? 氨酸是什么?类风湿性关节炎 类风湿性关节炎 类风湿性关节炎有针对性的治疗.托法西提尼布 (tofacitinib) 是一种可怕的药物.局部药物输送局部药物输送转基因组是通过转基因组的.更多相关视频
相关概念视频
Drug Distribution: Tissue Binding
2.5K
Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
For...
2.5K
T Cell Types and Functions
942
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
942
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
114
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
114
Drug Delivery: Miscellaneous Routes
305
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
305

